Menu
Home / Guides / Phentermine vs. tirzepatide
A short push, or the long haul.
Phentermine vs. Tirzepatide (2026): Short-Term Stimulant or Long-Term Shot?
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD (NPI 1144260043) · Updated
Phentermine is a low-cost, short-term stimulant, from $15.85 with a GoodRx coupon; tirzepatide is a long-term weekly shot, $299 or more a month as Zepbound at LillyDirect (November 1, 2026). Heart disease or uncontrolled blood pressure rules out phentermine; your conditions, timeline and coverage usually decide. At NexLife, compounded tirzepatide, which isn’t FDA-approved, is $115 a month on the 12-month plan, or $129 month to month, at every dose.
- Phentermine: a daily stimulant pill, labeled for a few weeks
- Tirzepatide: one shot a week, acting on GIP and
GLP-1 - Qsymia: phentermine plus topiramate in one capsule

$115/mo on a 12-month plan, all-inclusive, same price at every dose
Or $129/mo month to month
Zepbound at LillyDirect: $299 to $449 a month by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699
About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
See all 4 plans and what a year costs
| Plan | Per month | 12 months at this rate |
|---|---|---|
| 12-month Most savings | $115 | $1,380 |
| 6-month | $119 | $1,428 |
| 3-month | $125 | $1,500 |
| Month to month | $129 | $1,548 |
Month to month costs $168 more over 12 months than the 12-month plan. Plans renew until you cancel. Month to month is billed monthly. The 3-, 6- and 12-month plans are paid upfront at checkout: $375, $714 or $1,380.
Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works
4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026)LegitScript-certified
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.
- Licensed U.S. providers
- LegitScript certified
- Free expedited shipping
- HSA, FSA, Affirm, Klarna, Afterpay
- 24/7 support, real people
- Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)
Compounded tirzepatide isn’t FDA-approved, isn’t Zepbound or Mounjaro and wasn’t studied in their trials. A licensed provider prescribes it only when it offers a significant difference for you.
At a glance
Phentermine vs. tirzepatide: quick answers on results, risks and cost
From each label, not a head-to-head trial. Prices checked November 1, 2026.
| Question | Answer |
|---|---|
| What is each? | Phentermine is a Schedule IV stimulant pill, labeled for a few weeks. Tirzepatide is a weekly shot: Zepbound for weight, Mounjaro for type 2 diabetes. |
| Which lost more weight? | Tirzepatide: 15.0% to 20.9% average loss on Zepbound at 72 weeks, by dose (SURMOUNT-1), vs. 3.1% on placebo; compounded tirzepatide wasn’t studied. Phentermine added “only a fraction of a pound a week,” its label says. |
| Main side effects? | Phentermine: a faster pulse, higher blood pressure and poor sleep. Tirzepatide: mostly stomach and bowel, led by nausea (25% to 29% vs. 8% on placebo). |
| Can you take both? | Not as an FDA-approved pairing. Phentermine’s label advises against combining it with any other weight-loss drug. |
| Self-pay price? | Phentermine: from $15.85 for 30 tablets with a GoodRx coupon. Zepbound: $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. Checked November 15, 2026. |
| Who shouldn’t take it? | Phentermine: not with heart disease, uncontrolled blood pressure, glaucoma or an overactive thyroid. Tirzepatide: not with a personal or family history of MTC, or MEN 2. |
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Phentermine is a few-week stimulant; tirzepatide is a long-term weekly shot. In SURMOUNT-1, Zepbound averaged 15.0% to 20.9% loss at 72 weeks.
- Phentermine’s added loss was small: “only a fraction of a pound a week” over placebo, its label says.
- Your heart history matters. Phentermine is ruled out with heart disease or uncontrolled blood pressure; Zepbound’s label notes a small heart-rate rise.
- Phentermine is a controlled drug (Schedule IV), and pairing it with tirzepatide isn’t an FDA-approved treatment.
- Phentermine costs far less: from $15.85 for 30 tablets with a GoodRx coupon, against Zepbound’s $299 or more self-pay (November 1, 2026).
- At NexLife, compounded tirzepatide is $115 a month on the 12-month plan. It isn’t FDA-approved, and NexLife doesn’t prescribe phentermine.
At a glance
Phentermine vs. tirzepatide: how do they compare?
Phentermine is an older, low-cost stimulant meant for a few weeks and a controlled drug (Schedule IV). Tirzepatide is a newer weekly shot, sold as Zepbound and Mounjaro, for long-term use; in SURMOUNT-1, Zepbound averaged 15.0% to 20.9% loss at 72 weeks. Here they are, row by row, from each label.
| Phentermine | Tirzepatide (Zepbound, Mounjaro) | |
|---|---|---|
| Maker | Several generic makers; Adipex-P and Lomaira are brands | Eli Lilly, under two names: Zepbound for weight, Mounjaro for type 2 diabetes |
| Approved use | A short-term aid, “a few weeks,” alongside diet, exercise and behavior change, at a BMI of 30 or more, or 27 or more with a risk factor | Zepbound: losing weight and keeping it off in adults, and moderate to severe sleep apnea in adults with obesity. Mounjaro: type 2 diabetes, and heart risk in adults with it (August 2026) |
| Form | A pill once a day, before breakfast or 1 to 2 hours after; Lomaira, 8 mg three times a day before meals | A shot once a week: a single-dose pen or vial, or a 4-dose KwikPen |
| Dose rangeon the label | 37.5 mg a day, or half that (18.75 mg) | 2.5 mg for 4 weeks to start, then up in 2.5 mg steps at least 4 weeks apart, to 5, 10 or 15 mg |
| Main trial | None named on its label; its short studies added “only a fraction of a pound a week” over placebo | SURMOUNT-1 (2022): 15.0% to 20.9% average weight loss at 72 weeks, by dose, vs. 3.1% on placebo |
| Common side effectsfrom each label | Restlessness, insomnia, dry mouth, palpitations, raised blood pressure, constipation or diarrhea; no rates given | Nausea 25% to 29% (placebo 8%), diarrhea 19% to 23% (8%), constipation 11% to 17% (5%), vomiting 8% to 13% (2%) |
| Heart rate and blood pressure | Can raise both; ruled out with heart disease or uncontrolled blood pressure | In SURMOUNT-1, systolic pressure fell 6.6 to 7.7 points (1.0 on placebo), and pulse rose 0.6 to 2.6 beats a minute |
| Boxed warning | None | Thyroid C-cell tumors in rats; not for anyone with a personal or family history of MTC, or MEN 2 |
| Controlled substance | Schedule IV | No |
| Self-pay pricechecked November 1, 2026 | From $15.85 for 30 generic 37.5 mg tablets, GoodRx coupon | Zepbound $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699; Mounjaro $499 |
| Coverage, 2026–2027 | Some plans cover it but not weight-loss | Medicare’s Bridge: the Zepbound KwikPen at $50 a month if you qualify, through December 31, 2027. Lilly’s savings card ends December 31, 2026 |
From the Adipex-P and Lomaira labels, the Zepbound label (revised August 2026; SURMOUNT-1 is its Study 1), LillyDirect, Lilly’s savings terms, GoodRx and Medicare.gov, checked November 1, 2026. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied. CalPERS’s rule is on our California guide.
Which suits you
Which suits you: phentermine or tirzepatide?
Your health conditions, your timeline and your coverage usually decide it. Six situations, and what each label says:
If you have obstructive sleep apnea
Zepbound is approved for moderate to severe sleep apnea in adults with obesity; phentermine isn’t. Medicare’s
GLP-1 Bridge leaves out that diagnosis, though a Part D plan may cover Zepbound for it, Medicare.gov says.If your heart is a concern
Phentermine is off the table after coronary artery disease, a stroke, arrhythmias or heart failure, or with uncontrolled blood pressure. Zepbound’s label notes heart rate rising 1 to 3 beats a minute on average.
If the price is what stops you
Generic phentermine starts at $15.85 for 30 tablets with a GoodRx coupon (November 1, 2026), before the visit to get the prescription. At LillyDirect, Zepbound is $299 for the 2.5 mg starting dose. From 7.5 mg, it’s $449 with a refill within 45 days, otherwise $499 at 7.5 mg and $699 at 10 to 15 mg.
If you’d rather swallow a pill
Phentermine and Qsymia are pills. So is Foundayo, Lilly’s daily
GLP-1 pill: $149 to $299 a month at LillyDirect, by dose, with some prices reduced only through December 31, 2026. More on Foundayo.If you take birth control pills
Zepbound can make them work less well. Its label says to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and after each dose increase. Phentermine and Qsymia must not be used in pregnancy. For anyone who can become pregnant, Qsymia’s label calls for a negative pregnancy test before starting and every month, and effective birth control. With combined birth control pills, Qsymia can cause spotting. Don’t stop the pill because of it, but tell your provider if it’s troublesome.
If your coverage changes on January 1, 2027
Lilly’s Zepbound savings card for commercial coverage ends December 31, 2026, its terms say. In 2027, federal FEHB and PSHB plans will keep covering at least one
GLP-1 and two oral anti-obesity medicines. They’ll also require an intensive behavioral therapy program before and during treatment, OPM says. What’s changing in 2027.
One decision, made with your provider. These situations point the way. A licensed provider reviews your history and your other medicines before prescribing either one.
Step by step
How do you choose between phentermine and tirzepatide?
Start with what could rule either one out, then compare what each label covers, the results, side effects and cost.
- Check your health history first. Heart disease, uncontrolled blood pressure, glaucoma or an overactive thyroid rule out phentermine. A personal or family history of MTC, or MEN 2, rules out tirzepatide.
- Match each label to your needs. Phentermine’s label covers a few weeks, and tolerance usually develops within a few weeks. Zepbound’s label is for the long term, and it also covers moderate to severe sleep apnea in adults with obesity.
- Compare results as trial averages. In SURMOUNT-1, Zepbound averaged 15.0% to 20.9% weight loss at 72 weeks, by dose, vs. 3.1% on placebo; phentermine’s added loss was small. Neither label compares them directly, and compounded tirzepatide wasn’t studied.
- Weigh the side effects. Phentermine’s are a stimulant’s: a faster pulse, higher blood pressure and poor sleep, and it’s a controlled drug (Schedule IV). Tirzepatide’s are mostly stomach and bowel, led by nausea (25% to 29% on Zepbound vs. 8% on placebo).
- Compare what you’d pay. Phentermine: from $15.85 for 30 tablets with a GoodRx coupon, plus the prescriber’s visit. Zepbound: $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699 (November 1, 2026).
- Let your provider decide. Pairing them isn’t an FDA-approved treatment, and phentermine’s label advises against combining it with any other weight-loss drug. A licensed provider reviews your history and other medicines before prescribing either one.
A licensed provider makes the final call; NexLife’s providers prescribe compounded tirzepatide, not phentermine.
How they work
How do phentermine and tirzepatide curb appetite?
Phentermine is a stimulant, related to amphetamine, that decreases appetite. Tirzepatide works through two gut-hormone receptors, GIP and
Phentermine
A sympathomimetic amine whose activity resembles amphetamine’s, its label says. MedlinePlus puts it simply: it decreases appetite. The effect wears down, too: tolerance usually develops within a few weeks.
Tirzepatide
Zepbound’s label says it “selectively binds to and activates both the GIP and
GLP-1 receptors.”GLP-1 helps regulate appetite and how much you eat, and tirzepatide also delays gastric emptying.
Why that matters for timing. A pill whose effect fades within weeks suits a short push. A weekly shot whose dose steps up over months suits long-term care, which is what Zepbound’s label covers.
Two classes of drug. Phentermine is a controlled stimulant. Tirzepatide is neither a stimulant nor a controlled substance.
Results
Is tirzepatide stronger than phentermine for weight loss?
On the evidence in their labels, yes, by a wide margin, though neither label compares them directly. In SURMOUNT-1, Zepbound’s main trial, people averaged 15.0% to 20.9% loss at 72 weeks; phentermine’s label rests on studies lasting a few weeks, with a small added loss.
| At week 72 | Placebo | Zepbound 5 mg | Zepbound 10 mg | Zepbound 15 mg |
|---|---|---|---|---|
| Average weight change | −3.1% | −15.0% | −19.5% | −20.9% |
| Lost at least 5% | 34.5% | 85.1% | 88.9% | 90.9% |
| Lost at least 10% | 18.8% | 68.5% | 78.1% | 83.5% |
| Lost at least 15% | 8.8% | 48.0% | 66.6% | 70.6% |
| Lost at least 20% | 3.1% | 30.0% | 50.1% | 56.7% |
Swipe the table sideways to see every column.
SURMOUNT-1 (The New England Journal of Medicine, 2022), Study 1 in the Zepbound label (revised August 2026): 2,539 adults with obesity, or overweight with a weight-related condition, without type 2 diabetes; average starting weight 104.8 kg, BMI 38. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Phentermine’s side of the ledger. Its label sums up short studies of drugs like it: people lost more than on placebo, but the extra was “only a fraction of a pound a week,” and over diet alone its impact “must be considered clinically limited.”
Not a fair fight on paper. The studies differ in length, people and design, and neither label compares the two drugs, so these numbers can’t say what either would do for you.
When tirzepatide’s results tend to show, week by week: the tirzepatide results timeline.
Qsymia
What is Qsymia, and how is it different from phentermine?
Qsymia combines phentermine with topiramate in one extended-release capsule. It isn’t plain phentermine: it has its own dose steps, warnings and rules.
| What it is | Phentermine and topiramate together in one extended-release capsule, a prescription weight-loss medicine |
|---|---|
| Approved for | Long-term weight loss with diet and exercise in adults with obesity, or overweight with a weight-related condition, and in children 12 and older with obesity (first approved in 2012) |
| How it’s taken | Once a day in the morning: 3.75 mg/23 mg for 14 days, then 7.5 mg/46 mg. The label allows steps to 11.25 mg/69 mg and 15 mg/92 mg, depending on response |
| Who shouldn’t take it | Anyone pregnant, or with glaucoma or an overactive thyroid, after an MAOI in the past 14 days, or with a sensitivity to stimulant-type drugs |
| Pregnancy rules | For anyone who can become pregnant: a negative pregnancy test before starting and every month while taking it, plus effective birth control, its label says. It’s sold only through certified pharmacies, under a safety program the FDA requires (a REMS) |
| Most common side effects | Tingling (paresthesia), dizziness, a change in taste, insomnia, constipation and dry mouth, each in 5% or more of trial patients |
| Serious risks on its label | Harm to an unborn baby, suicidal thoughts and behavior, a sudden form of glaucoma, mood and sleep problems, problems with thinking (cognitive impairment), metabolic acidosis, kidney stones and seizures if it’s stopped suddenly, among others |
| Heart rate | Raised the 24-hour average heart rate by 3.6 beats a minute over placebo in an 8-week study in adults, its label says |
| Controlled? | Yes: its phentermine is a Schedule IV controlled substance |
| Kidneys and liver | With moderate or severe kidney impairment, or moderate liver impairment, the label caps the dose at 7.5 mg/46 mg |
Qsymia vs. Zepbound, in short. One is a daily capsule that works through phentermine and topiramate; the other, a weekly shot that acts on GIP and
Mood is another difference. Qsymia’s label counts suicidal behavior and ideation, and mood and sleep disorders, among its serious risks. Zepbound’s label dropped its suicidal-behavior warning in February 2026.
No side-by-side trial on the label. Zepbound’s label compares it only with placebo.
Qsymia’s facts are from its prescribing information (Vivus, revised April 2026, on DailyMed), read November 1, 2026.
Mounjaro
Phentermine vs. Mounjaro: which fits type 2 diabetes?
Mounjaro is the tirzepatide approved for type 2 diabetes. Phentermine isn’t a diabetes medicine, though its label has a warning for people who take one.
| Mounjaro | Tirzepatide for type 2 diabetes, ages 10 and up, and, since August 2026, for lowering the risk of heart attack, stroke and heart-related death in adults with type 2 diabetes at high risk for them, Lilly says. Single-dose pens, 2.5 mg to 15 mg; $499 a month self-pay at LillyDirect, at every dose |
|---|---|
| Zepbound | Also tirzepatide from Eli Lilly, approved for weight loss and sleep apnea. $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699 |
| Mounjaro for weight loss alone | Off-label: its approved uses are for type 2 diabetes |
| Phentermine with diabetes | Its label says insulin or diabetes pill doses may need to come down in some people |
| Low blood sugar on tirzepatide | More likely when it’s taken with insulin or a medicine that boosts insulin release, such as a sulfonylurea, Zepbound’s label says |
From LillyDirect, Lilly’s announcement of August 28, 2026, and the Zepbound and Adipex-P labels, read November 1, 2026.
Medicare and diabetes. People with type 2 diabetes can’t use Medicare’s
Don’t double up. Zepbound’s label doesn’t recommend using it with other tirzepatide products, Mounjaro included, or with any
Compounded tirzepatide and diabetes. NexLife’s providers prescribe compounded tirzepatide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace Mounjaro or your diabetes care.
Side effects
Phentermine vs. tirzepatide side effects: heart, sleep or stomach?
Phentermine’s side effects are a stimulant’s: a faster pulse, higher blood pressure, jitters and poor sleep. Tirzepatide’s are mostly in the stomach and bowel, such as nausea and diarrhea; in Zepbound’s main trial, blood pressure went down, though its label notes a small heart-rate rise.
| Side effect | Placebo | Zepbound 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Nausea | 8% | 25% | 29% | 28% |
| Diarrhea | 8% | 19% | 21% | 23% |
| Vomiting | 2% | 8% | 11% | 13% |
| Constipation | 5% | 17% | 14% | 11% |
| Belly pain | 5% | 9% | 9% | 10% |
| Indigestiondyspepsia | 4% | 9% | 9% | 10% |
| Tirednessfatigue | 3% | 5% | 6% | 7% |
| Stopped because of side effects | 3.4% | 4.8% | 6.3% | 6.7% |
Adults with obesity or overweight in Zepbound’s two placebo-controlled weight trials, pooled (Study 2 enrolled people with type 2 diabetes), up to 72 weeks; Zepbound label (revised August 2026), Table 1 and section 6.1. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Blood pressure and pulse on Zepbound
| Change at week 72 | Placebo | Zepbound 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Systolic blood pressuremmHg | −1.0 | −6.6 | −7.7 | −7.4 |
| Diastolic blood pressuremmHg | −0.8 | −4.9 | −5.0 | −4.5 |
| Pulsebeats a minute | +0.1 | +0.6 | +2.3 | +2.6 |
Swipe the table sideways to see every column.
SURMOUNT-1 (2022), Study 1 in the Zepbound label (revised August 2026), Table 3. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Phentermine’s label gives no rates. It lists side effects by body system. Heart and circulation: palpitations, a fast pulse, raised blood pressure and ischemic events (problems from reduced blood flow to the heart or brain), with rare primary pulmonary hypertension and heart-valve disease. Brain and nerves: overstimulation, restlessness, dizziness, sleeplessness, euphoria or dysphoria, tremor, headache and psychosis. Mouth and gut: dry mouth, a bad taste, diarrhea or constipation. Other: hives, and impotence or a change in libido.
Sleep. Phentermine’s label warns against a late-evening dose because of insomnia. Insomnia isn’t among Zepbound’s listed common side effects; tiredness is, in 5% to 7% on Zepbound vs. 3% on placebo. More: why tirzepatide can make you tired.
Habit risk. Phentermine is a Schedule IV controlled substance, and tolerance to it builds within weeks. Stopping suddenly after long, high-dose use can cause extreme fatigue and depression. Tirzepatide isn’t controlled.
What helps with stomach side effects: tirzepatide side effects.
Together?
Can you take phentermine with tirzepatide?
Not as an FDA-approved pairing. Phentermine’s label advises against combining it with any other weight-loss drug, over-the-counter and herbal ones included, and Zepbound’s label doesn’t address other weight-loss drugs. Any use together is off-label and your provider’s decision; NexLife doesn’t prescribe phentermine.
“indicated only as short-term (a few weeks) monotherapy”
- Monotherapy means on its own. The label means phentermine to be your only weight-loss drug, and doesn’t recommend adding others, over-the-counter and herbal products included.
- It also lists SSRI antidepressants, such as paroxetine or fluvoxamine, among the pairings with no established safety.
- Zepbound’s limits are other tirzepatide products and
GLP-1 medicines. Its label doesn’t address other weight-loss drugs. - Tirzepatide delays gastric emptying, which can change how other medicines you swallow are absorbed.
- Both can move your heart rate: phentermine through stimulation, Zepbound by 1 to 3 beats a minute on average.
Ask before you add anything. Bring your provider a list of every medicine and supplement you take.
In their words
Phentermine and tirzepatide together: what do the labels say?
Phentermine’s label weighs pairing it with any other weight-loss drug, over-the-counter and herbal ones included, or an SSRI, then concludes:
“Therefore, coadministration of ADIPEX-P® and these drug products is not recommended.”
Teva, Adipex-P (phentermine hydrochloride) prescribing information, section 5.1, revised March 2024
Zepbound’s label draws its line at a different pairing, which matters if you also take Mounjaro or another GLP-1:
“ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, section 1, revised August 2026
Cost
What do phentermine and tirzepatide cost, every way to pay?
Generic phentermine is the low-cost option: GoodRx prices start at $15.85. Zepbound is $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. Mounjaro, for type 2 diabetes, is $499 (checked November 15, 2026).
| Route | Price | What to know |
|---|---|---|
| Generic phentermine, 37.5 mgGoodRx coupon price | From $15.85 30 tablets | The visit to get the prescription is separate |
| Phentermine from an online clinicHenry Meds, for example | $149 | Its price list, read November 1, 2026 |
| Zepbound KwikPen or vialsLillyDirect, self-pay | $299 to $449 | $299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg if you refill within 45 days; otherwise $499 to $699. A month is 28 days |
| A first year of ZepboundLillyDirect, each refill within 45 days | $5,637 a year | $299 + $399 + 11 refills at $449 from 7.5 mg: 13 fills, because a month is 28 days. Without a refill within 45 days, it’s $499 to $699 |
| Zepbound on TrumpRx.gov | Starting at $299 | Vial orders go through LillyDirect |
| MounjaroLillyDirect, for type 2 diabetes | $499 | The same price at every dose |
| Zepbound savings cardcommercial insurance | As little as $25 | Up to $100 off a month and $1,300 a year, for the single-dose pen. Ends December 31, 2026; not with government coverage |
| Medicare | $50 | The Zepbound KwikPen only, not vials or single-dose pens, through December 31, 2027, with prior authorization |
| Compounded tirzepatide online25 programs with a month-to-month price; not FDA-approved | $126 to $599 | Month to month and all in; median $285, checked Nov. 15, 2026. Pay less than NexLife elsewhere? Our Price Match Guarantee† matches it |
| NexLife,compounded tirzepatide, 12-month plan; not FDA-approved | $115 | Paid upfront: $1,380 for 12 months; the same at every dose |
| NexLife,compounded tirzepatide, month to month | $129 | $1,548 a year |
NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works
Swipe the table sideways to see every column.
Checked November 1, 2026 at GoodRx, LillyDirect, Lilly’s savings terms, TrumpRx.gov and Medicare.gov. Henry Meds’ price is from our Henry Meds review (November 1, 2026); compounded prices from our
The difference, as arithmetic. A LillyDirect month of Zepbound is 28 days. So a year at $449 (7.5 mg and up, each refill within 45 days; otherwise $499 to $699) is 13 fills, or $5,837. Compounded tirzepatide on NexLife’s 12-month plan is $115 a month, or $1,380 a year: $4,457 less. They’re different products: Zepbound is FDA-approved, and compounded tirzepatide isn’t.
Phentermine stays cheapest, but its label covers only a few weeks of use.
Plans differ. HealthSelect of Texas, the main state employee plan, excludes drugs used only for weight loss, Zepbound and Qsymia among them (Texas guide).
Who should avoid
Who should avoid phentermine or tirzepatide, and what needs a call?
Heart disease, glaucoma, an overactive thyroid, agitation, past drug abuse, pregnancy or a recent MAOI rule out phentermine, its label says. A personal or family history of medullary thyroid cancer, or MEN 2, rules out tirzepatide.
Tirzepatide’s boxed warning: thyroid C-cell tumors. Tirzepatide caused thyroid C-cell tumors in rats; whether it does in people is unknown. Don’t use it with a personal or family history of medullary thyroid carcinoma (MTC), or with multiple endocrine neoplasia syndrome type 2 (MEN 2). Phentermine’s label carries no boxed warning.
Avoid phentermine with
- A history of heart disease, including stroke, arrhythmias or heart failure
- High blood pressure that isn’t under control
- An MAOI taken in the last 14 days
- Hyperthyroidism or glaucoma
- An agitated state, or past drug abuse
- Being pregnant or nursing
- A known allergy or unusual reaction to stimulant-type drugs
- Being 16 or under, or on dialysis
Avoid tirzepatide with
- A personal or family history of MTC, or MEN 2
- A serious allergy to tirzepatide or its ingredients
- A pregnancy: stop once it’s recognized
- Mounjaro or another tirzepatide product, or another
GLP-1
Warning signs that need a call
| Warning sign | What it can mean | What to do |
|---|---|---|
| Chest pain, fainting, new shortness of breath, or swollen legson phentermine | Rare lung blood-pressure or heart-valve problems | Stop phentermine and call your provider now |
| A heart that races at rest, or blood pressure readings that climbon phentermine | A stimulant side effect | Call your provider right away |
| Severe stomach pain that won’t go away, sometimes reaching your backon tirzepatide | Pancreatitis | Stop tirzepatide and call your provider right away |
| Upper stomach pain, fever, yellow skin or eyes, or clay-colored stoolson tirzepatide | Gallbladder problems | Call your provider |
| Nausea, vomiting or diarrhea that won’t stopon tirzepatide | Dehydration, which can lead to kidney problems | Drink fluids and call your provider |
| Swelling of the face, lips or throat, or trouble breathing or swallowingon tirzepatide | A serious allergic reaction | Stop tirzepatide and get emergency care |
| A neck lump, hoarseness, trouble swallowing or shortness of breathon tirzepatide | A possible thyroid tumor | Tell your provider |
| Sudden, painless vision loss in one eyeon tirzepatide | NAION, a rare optic nerve problem the FDA warned about on Nov. 9, 2026 (FDA) | Call your provider right away |
Swipe the table sideways to see every column.
From the Adipex-P label (revised March 2024), MedlinePlus, the Zepbound prescribing information (revised August 2026) and the FDA’s Nov. 9, 2026, NAION safety communication. Your provider’s instructions come first.
On birth control pills? Switch to a non-oral method, or add a barrier method, for 4 weeks after starting tirzepatide and after each dose increase, its label says.
Planning surgery? Tell the team you take tirzepatide. Its label warns about pulmonary aspiration under general anesthesia or deep sedation.
At NexLife
What do you get with tirzepatide at NexLife, and what does it cost?
Compounded tirzepatide, if prescribed, for $115 a month on 12 months, $119 on 6, $125 on 3 or $129 month to month, at every dose, with no membership fee. That covers your provider, the medication, a nutrition plan, a coaching call and free expedited shipping. NexLife doesn’t prescribe phentermine.
NexLife prescribes compounded tirzepatide and compounded semaglutide, which aren’t FDA-approved. It doesn’t prescribe phentermine, Qsymia or brand-name Zepbound, and a licensed provider decides whether treatment is right for you.
| 12-month plan | $115 a month |
|---|---|
| 6-month plan | $119 a month |
| 3-month plan | $125 a month |
| Month to month | $129 a month |
Your dose climbs; your bill doesn’t. Every dose from 2.5 mg to 15 mg costs the same, and there’s no membership fee.
In the price: your licensed provider, who follows your dose, and the medication. Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA) fills it; both are state-licensed 503A pharmacies. You also get a nutrition plan, a 1:1 coaching call and free expedited shipping. People answer 24/7 at
Getting started: about 3 minutes online, then a licensed provider’s review online. If you’re prescribed, the partner pharmacy ships; if you’re not, you pay nothing for medication.
Paying: HSA or FSA cards, with a letter of medical necessity from NexLife, or Affirm, Klarna and Afterpay at checkout. People with Medicare can self-pay, though the Bridge’s $50 for the Zepbound KwikPen costs less if you qualify.
Switching from another program? Send a receipt from the last 60 days, and our Price Match Guarantee† matches the regular monthly price you pay for compounded tirzepatide elsewhere.
4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026); LegitScript-certified.
Compounded tirzepatide isn’t FDA-approved, isn’t Zepbound or Mounjaro and wasn’t studied in their trials. A licensed provider prescribes it only when it offers a significant difference for you.
Vial math
How many units is your tirzepatide dose?
Your tirzepatide dose in units depends on your vial’s strength. Here are the label’s doses at one example strength, with the math to check your own.
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart. Or enter your own vial’s strength in the tirzepatide dosage calculator.
Loved by our members
Real stories from NexLife members about their care and service.
A selection of 5-star reviews from Trustpilot, quoted in full as written. Results vary from person to person, and weight loss isn’t guaranteed.
★★★★★TrustScore 4.8 out of 5 on Trustpilot407 reviews as of Nov. 15, 2026 · Read them all ↗
★★★★★Read on Trustpilot ↗
“Affordable, quick and easy. They could not have made it a smoother less stressful experience.”
Andisheh K.
★★★★★Read on Trustpilot ↗
“Great communication. Easy to work with. They work to set you up for success.”
Anthony C.
★★★★★Read on Trustpilot ↗
“Fast delivery and easy to get a hold of when needing to talk with someone!”
Browneyes
★★★★★Read on Trustpilot ↗
“So happy with NexLife. Communication has been great, I’m recommending them to all my friends.”
April
★★★★★Read on Trustpilot ↗
“Excellent visit. Dr. Kennah was very knowledgeable and helpful and answered all my questions.”
Ethan B.
★★★★★Read on Trustpilot ↗
“That’s a real site with good prices and plans!”
Estefany L.
★★★★★Read on Trustpilot ↗
“Great service and excellent communication!”
Gabrielle D.
★★★★★Read on Trustpilot ↗
“Easy and pricing not bad! Customer service was helpful in answering my questions.”
Lyndy T.
★★★★★Read on Trustpilot ↗
“Good experience, great team”
Mai S.
★★★★★Read on Trustpilot ↗
“Great communciation and was fast and reliable”
Kiki
★★★★★Read on Trustpilot ↗
“Very happy so far”
Tammy E.
★★★★★Read on Trustpilot ↗
“Fast service great communication!! Willing to work with you!”
Bon
Names are shortened for privacy. Reviews are members’ opinions, not medical advice.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $115/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan, $1,380 paid upfront; $129/mo month to month, billed monthly.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication

12-month plan $95/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
TrustScore 4.8 out of 5 on Trustpilot 407 reviews as of Nov. 15, 2026 · Read them all ↗
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Phentermine vs. tirzepatide: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
What’s the difference between phentermine and tirzepatide?
Phentermine is a Schedule IV stimulant pill labeled for a few weeks; tirzepatide (Zepbound) is a weekly shot for the long term. Phentermine costs far less. Zepbound is $299 to $449 a month at LillyDirect, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. Your provider decides which suits your health.
Does NexLife prescribe phentermine or Qsymia?
No. NexLife prescribes compounded tirzepatide and semaglutide only. Compounded tirzepatide is $115 a month on the 12-month plan, or $129 month to month, the same at every dose. It isn’t Zepbound and isn’t FDA-approved, and a licensed provider decides whether it suits you.
Can you take phentermine with tirzepatide?
Not as an approved treatment. Phentermine’s label calls it short-term monotherapy and doesn’t recommend combining it with other weight-loss drugs. Zepbound’s label advises against only other tirzepatide and
Is Qsymia the same as phentermine?
No. Qsymia pairs phentermine with topiramate in one extended-release capsule, taken each morning and stepped up from 3.75 mg/23 mg. Like phentermine, it’s ruled out in pregnancy and with glaucoma, an overactive thyroid or a recent MAOI. Plain phentermine’s label limits it to a few weeks.
How is Qsymia different from Zepbound?
Qsymia is a daily capsule of phentermine and topiramate; Zepbound is a weekly tirzepatide shot. Qsymia’s most common side effects include tingling, dizziness, taste changes and insomnia; Zepbound’s are mostly nausea and diarrhea. Qsymia must not be used in pregnancy, and Zepbound should be stopped once a pregnancy is recognized.
Is phentermine cheaper than Zepbound?
By far: GoodRx listed 30 phentermine 37.5 mg tablets from $15.85 with its coupon on November 1, 2026. LillyDirect charges $299 to $449 a month for Zepbound, by dose; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. Phentermine is labeled for a few weeks, and Zepbound for long-term use.
Is Mounjaro or phentermine better if you have type 2 diabetes?
Mounjaro is the tirzepatide approved for type 2 diabetes, for ages 10 and up, Lilly says. Phentermine isn’t a diabetes medicine, and its label warns that insulin or diabetes pill doses may need lowering. Taking Mounjaro for weight loss alone is off-label. Your provider weighs your blood sugar, heart and weight together.
Does phentermine or tirzepatide affect sleep?
Phentermine is the one tied to sleep: insomnia is on its label, which warns against late-evening doses. Insomnia isn’t among Zepbound’s listed common side effects; tiredness is, in 5% to 7% on Zepbound vs. 3% on placebo. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Is tirzepatide stronger than phentermine?
On the evidence, yes. In SURMOUNT-1 (2022), adults lost 15.0% to 20.9% of their weight on average at 72 weeks on Zepbound, vs. 3.1% on placebo. Phentermine’s short studies added “only a fraction of a pound a week” over placebo. Neither label compares them directly. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Does tirzepatide raise blood pressure like phentermine?
No: in SURMOUNT-1 (2022), systolic blood pressure fell 6.6 to 7.7 points on Zepbound by week 72, vs. 1.0 on placebo, while pulse rose 0.6 to 2.6 beats a minute. Phentermine’s label lists raised blood pressure and rules it out when blood pressure isn’t controlled. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Is phentermine a controlled substance?
Yes. Phentermine is a Schedule IV controlled substance, and tolerance to it builds within weeks. Stopping suddenly after long, high-dose use can cause extreme fatigue and depression. Qsymia’s phentermine is Schedule IV too. Tirzepatide is neither a stimulant nor a controlled substance.
Is tirzepatide approved for sleep apnea?
Yes, as Zepbound: it’s approved for moderate to severe sleep apnea in adults with obesity; phentermine isn’t. Medicare’s GLP-1 Bridge leaves out that diagnosis, though a Part D plan may cover Zepbound for it, Medicare.gov says. Compounded tirzepatide isn’t Zepbound, isn’t FDA-approved and wasn’t studied in its trials.
Does insurance cover phentermine or Zepbound?
Plans differ. Some cover phentermine but not weight-loss GLP-1s, such as CalPERS’s self-funded plans, while HealthSelect of Texas excludes drugs used only for weight loss, Zepbound and Qsymia among them. With Medicare, the GLP-1 Bridge covers the Zepbound KwikPen at $50 a month if you qualify, through December 31, 2027; phentermine isn’t in it.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation and stomach pain.
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Labels, Lilly’s prices and Medicare rules checked Nov. 1, 2026; price-index figures checked Nov. 15, 2026.
- How we checked. Phentermine’s facts come from the Adipex-P label (revised March 2024, from the FDA’s label database), the Lomaira label and MedlinePlus; Qsymia’s from its prescribing information (revised April 2026, DailyMed); tirzepatide’s from the Zepbound prescribing information (revised August 2026) and Lilly’s own pages, including its announcement of Mounjaro’s heart indication (August 28, 2026), all read November 1, 2026. Prices come from GoodRx, LillyDirect, Lilly’s savings terms, TrumpRx.gov and Medicare.gov, checked the same day; compounded prices from our
GLP-1 price index (checked Nov. 15, 2026). Each trial result carries its name and year, and we don’t treat separate trials as head to head. Zepbound, Mounjaro and Foundayo are trademarks of Eli Lilly and Company; Qsymia, Adipex-P and Lomaira are trademarks of their owners. NexLife isn’t affiliated with any of them. - Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
- How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves
Paying less elsewhere? We match it.†
You’ve seen both sides. Next: a 3-minute check.
A licensed provider reviews your history and decides whether compounded tirzepatide fits: $115 a month on the 12-month plan, or $129 month to month, at every dose.
4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Adipex-P (phentermine hydrochloride) prescribing information, Teva, revised March 2024 (FDA label database). Read November 1, 2026.
- Lomaira (phentermine hydrochloride) 8 mg prescribing information, KVK-Tech (label copy on Drugs.com). Read November 1, 2026.
- MedlinePlus: Phentermine. Read November 1, 2026.
- Qsymia (phentermine and topiramate extended-release) prescribing information, Vivus, revised April 2026 (DailyMed). Read November 1, 2026.
- Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026. Read November 15, 2026.
- Eli Lilly: FDA approves Mounjaro to reduce cardiovascular risk in adults with type 2 diabetes (August 28, 2026). Read November 1, 2026.
- LillyDirect: Zepbound self-pay prices. Checked November 15, 2026.
- LillyDirect: Mounjaro self-pay prices. Checked November 15, 2026.
- LillyDirect: Foundayo self-pay prices. Checked November 15, 2026.
- Eli Lilly: Zepbound savings card terms. Read November 15, 2026.
- GoodRx: phentermine vs. Zepbound, with coupon prices. Checked November 15, 2026.
- Drugs.com: Mounjaro vs. phentermine (controlled-substance status). Checked November 1, 2026.
- TrumpRx.gov: Zepbound vial. Checked November 15, 2026.
- Medicare.gov: Weight loss drugs (the Medicare
GLP-1 Bridge). Read November 15, 2026. - CMS: Medicare
GLP-1 Bridge. Read November 15, 2026. - OPM: Federal Benefits Open Season Highlights, 2027 plan year. Read November 15, 2026.
- FDA: Compounding and the FDA, questions and answers.
- NexLife:
GLP-1 price index. Compounded tirzepatide prices checked Nov. 15, 2026. - NexLife: Henry Meds reviews (Henry Meds’ price list). Checked November 1, 2026.
- NexLife: best tirzepatide providers in Texas (HealthSelect rules, seen there November 1, 2026). Read November 1, 2026.
- NexLife: best tirzepatide providers in California (CalPERS board item, June 2026). Read November 1, 2026.
- NexLife: pricing, every plan.